SCHEMBL15380562

SCHEMBL15380562

NC(=O)c1c(N)ccnc1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 3/20 0.44
MKNK2 Q9HBH9 3/20 0.44
HSD17B10 Q99714 2/20 0.41
HTT P42858 1/20 0.41
NNMT P40261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CSNK2A1 P68400 1/20 0.40
HIPK2 Q9H2X6 1/20 0.40
NAPRT Q6XQN6 1/20 0.39
ROCK1 Q13464 1/20 0.38
KDM4B O94953 1/20 0.38
KDM5C P41229 1/20 0.38
KDM5B Q9UGL1 1/20 0.38
F7 P08709 1/20 0.36
F3 P13726 1/20 0.36
SARM1 Q6SZW1 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
SIRT6 Q8N6T7 1/20 0.36
SIRT1 Q96EB6 1/20 0.36
SIRT3 Q9NTG7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22688908 0.83 NAPRT (0.48) HSD17B10HTTSMN1; SMN2NAPRTKDM4B
SCHEMBL7718372 0.81 KDM4E (0.43) MKNK1MKNK2NNMTSMN1; SMN2CSNK2A1
SCHEMBL29275431 0.81 HSD17B10 (0.40) MKNK1MKNK2HSD17B10HTTNNMT
SCHEMBL1058104 0.79 HTT (0.39) MKNK1MKNK2HSD17B10HTTNNMT
SCHEMBL14917427 0.79 NOS2 (0.52) MKNK1MKNK2NAPRTSIRT3LIMK1
SCHEMBL14917426 0.79 MKNK1 (0.41) MKNK1MKNK2HSD17B10HTTNNMT
SCHEMBL7655168 0.76 PIK3C3 (0.38) HSD17B10HTTNAPRTNOS3NOS2
SCHEMBL14917466 0.76 NOS2 (0.43) MKNK1MKNK2NAPRTPIK3CBNOS3
SCHEMBL27610033 0.76 ALDH1A1 (0.46) HSD17B10HTTROCK1KDM5CMAPT
SCHEMBL17490709 0.75 IKBKB (0.50) NNMTCHEK2POLBTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130303563-A1 TREATMENT OF PERITONEAL INJURY USING JAK INHIBITORS LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER 2013-11-14 US claimed
US-20160193203-A1 TREATMENT OF PERITONEAL INJURY USING JAK INHIBITORS LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER 2016-07-07 US disclosed
CN-105481778-A Pyrimidine derivative, preparation method and applications thereof SHENZHEN CHIPSCREEN BIOSCIENCES LTD 2016-04-13 CN disclosed
CN-105399686-A Pyrimidine derivative, preparation method and applications thereof SHENZHEN CHIPSCREEN BIOSCIENCES LTD 2016-03-16 CN disclosed
CN-105399685-A Preparation method and applications of aromatic heterocyclic compound adopted as selective JAK3 and/or JAK1 kinase inhibitor SHENZHEN CHIPSCREEN BIOSCIENCES LTD 2016-03-16 CN disclosed
US-9198900-B2 Treatment of peritoneal injury using JAK inhibitors LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) 2015-12-01 US disclosed
CN-103059019-B Imidazoles [4,5-c] pyridine-7-carboxamides derivatives, its method for making and medicinal use HEFEI YIGONG MEDICINE CO., LTD. (CN) 2015-11-04 CN disclosed
US-20130303563-A1 TREATMENT OF PERITONEAL INJURY USING JAK INHIBITORS LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER 2013-11-14 US disclosed
CN-101228162-A 2-phenyl substituted imidazol [4,5b]pyridine/ pyrazine and purine derivatives as glucokinase modulators ASTRAZENECA AB (SE) 2008-07-23 CN disclosed
CN-1255404-C Process for preparing substituted imidazopyridine compounds ASTRAZENECA AB (SE) 2006-05-10 CN disclosed
CN-1452621-A Process for preparing substd. imidazopyridine compound ASTRAZENECA AB (SE) 2003-10-29 CN disclosed